| Stephen J Handrich, MD | |
|
6150 West Layton Avenue, Greenfield, WI 53220 | |
| (414) 282-4100 | |
| (414) 282-4108 |
| Full Name | Stephen J Handrich |
|---|---|
| Gender | Male |
| Speciality | Diagnostic Radiology |
| Experience | 26 Years |
| Location | 6150 West Layton Avenue, Greenfield, Wisconsin |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1265454003 | NPI | - | NPPES |
| 34582700 | Medicaid | WI |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 2085R0202X | Radiology - Diagnostic Radiology | 46578020 (Wisconsin) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Beaver Dam Community Hospital Dba Marshfield Medical Center - Beaver Dam | Beaver dam, WI | Hospital |
| Ascension Se Wisconsin Hospital - St Joseph Campus | Milwaukee, WI | Hospital |
| Gundersen Lutheran Medical Center | La crosse, WI | Hospital |
| Marshfield Medical Center | Marshfield, WI | Hospital |
| Marshfield Medical Center - Eau Claire | Eau claire, WI | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Medical Diagnostic Imaging Llc | 0042107641 | 16 |
| Moundview Memorial Hospital And Clinics Inc | 1355250432 | 29 |
| Gundersen Lutheran Medical Center Inc | 2163331414 | 800 |
| Marshfield Clinic Inc | 2264345206 | 99 |
| Tri-county Memorial Hospital Inc | 4587642418 | 56 |
| Mchs Hospitals Inc | 5698071173 | 1049 |
| Milwaukee Radiologists Ltd Sc | 7113915810 | 19 |
| Memorial Hospital Of Boscobel | 8325957673 | 43 |
News Archive
Advion, Inc., a leading systems and consumables developer for the life sciences industry, announces the release of a Direct Analysis Probe for its line of expression compact mass spectrometers (CMS). With hundreds of CMS systems utilized in chemistry laboratories around the world, this latest development creates yet another important tool for chemists that need fast, simple, reliable sample analysis of liquids and solids such as reaction mixtures, food samples, natural products and tablets without the need for sample preparation.
Nisin, a common food preservative, may slow or stop squamous cell head and neck cancers, a University of Michigan study found.
Tioga Pharmaceuticals, Inc. announced today that the company has dosed its first subject in a Phase 3 clinical trial to evaluate asimadoline for the treatment of patients with diarrhea-predominant irritable bowel syndrome (DIBS). The trial, referred to as ASMP3001, is the first of two Phase 3 trials being conducted under a Special Protocol Assessment (SPA) agreement with the U.S. Food and Drug Administration (FDA) for U.S. registration. This first trial will be conducted at 120 sites in the U.S.
NeoStem, Inc. an international biopharmaceutical company with product and service revenues, global research and development capabilities and operations in three distinct business units, U.S. adult stem cells, China adult stem cells, and China pharmaceuticals is today providing results of its second quarter 2010.
› Verified 5 days ago
| Entity Name | Gundersen Clinic Ltd |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1851343115 PECOS PAC ID: 9638082779 Enrollment ID: O20031106000139 |
News Archive
Advion, Inc., a leading systems and consumables developer for the life sciences industry, announces the release of a Direct Analysis Probe for its line of expression compact mass spectrometers (CMS). With hundreds of CMS systems utilized in chemistry laboratories around the world, this latest development creates yet another important tool for chemists that need fast, simple, reliable sample analysis of liquids and solids such as reaction mixtures, food samples, natural products and tablets without the need for sample preparation.
Nisin, a common food preservative, may slow or stop squamous cell head and neck cancers, a University of Michigan study found.
Tioga Pharmaceuticals, Inc. announced today that the company has dosed its first subject in a Phase 3 clinical trial to evaluate asimadoline for the treatment of patients with diarrhea-predominant irritable bowel syndrome (DIBS). The trial, referred to as ASMP3001, is the first of two Phase 3 trials being conducted under a Special Protocol Assessment (SPA) agreement with the U.S. Food and Drug Administration (FDA) for U.S. registration. This first trial will be conducted at 120 sites in the U.S.
NeoStem, Inc. an international biopharmaceutical company with product and service revenues, global research and development capabilities and operations in three distinct business units, U.S. adult stem cells, China adult stem cells, and China pharmaceuticals is today providing results of its second quarter 2010.
› Verified 5 days ago
| Entity Name | Marshfield Clinic Inc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1952347981 PECOS PAC ID: 2264345206 Enrollment ID: O20031106000590 |
News Archive
Advion, Inc., a leading systems and consumables developer for the life sciences industry, announces the release of a Direct Analysis Probe for its line of expression compact mass spectrometers (CMS). With hundreds of CMS systems utilized in chemistry laboratories around the world, this latest development creates yet another important tool for chemists that need fast, simple, reliable sample analysis of liquids and solids such as reaction mixtures, food samples, natural products and tablets without the need for sample preparation.
Nisin, a common food preservative, may slow or stop squamous cell head and neck cancers, a University of Michigan study found.
Tioga Pharmaceuticals, Inc. announced today that the company has dosed its first subject in a Phase 3 clinical trial to evaluate asimadoline for the treatment of patients with diarrhea-predominant irritable bowel syndrome (DIBS). The trial, referred to as ASMP3001, is the first of two Phase 3 trials being conducted under a Special Protocol Assessment (SPA) agreement with the U.S. Food and Drug Administration (FDA) for U.S. registration. This first trial will be conducted at 120 sites in the U.S.
NeoStem, Inc. an international biopharmaceutical company with product and service revenues, global research and development capabilities and operations in three distinct business units, U.S. adult stem cells, China adult stem cells, and China pharmaceuticals is today providing results of its second quarter 2010.
› Verified 5 days ago
| Entity Name | Moundview Memorial Hospital & Clinics Inc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1710939533 PECOS PAC ID: 1355250432 Enrollment ID: O20031121000846 |
News Archive
Advion, Inc., a leading systems and consumables developer for the life sciences industry, announces the release of a Direct Analysis Probe for its line of expression compact mass spectrometers (CMS). With hundreds of CMS systems utilized in chemistry laboratories around the world, this latest development creates yet another important tool for chemists that need fast, simple, reliable sample analysis of liquids and solids such as reaction mixtures, food samples, natural products and tablets without the need for sample preparation.
Nisin, a common food preservative, may slow or stop squamous cell head and neck cancers, a University of Michigan study found.
Tioga Pharmaceuticals, Inc. announced today that the company has dosed its first subject in a Phase 3 clinical trial to evaluate asimadoline for the treatment of patients with diarrhea-predominant irritable bowel syndrome (DIBS). The trial, referred to as ASMP3001, is the first of two Phase 3 trials being conducted under a Special Protocol Assessment (SPA) agreement with the U.S. Food and Drug Administration (FDA) for U.S. registration. This first trial will be conducted at 120 sites in the U.S.
NeoStem, Inc. an international biopharmaceutical company with product and service revenues, global research and development capabilities and operations in three distinct business units, U.S. adult stem cells, China adult stem cells, and China pharmaceuticals is today providing results of its second quarter 2010.
› Verified 5 days ago
| Entity Name | Memorial Hospital Of Boscobel |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1760459846 PECOS PAC ID: 8325957673 Enrollment ID: O20040115000725 |
News Archive
Advion, Inc., a leading systems and consumables developer for the life sciences industry, announces the release of a Direct Analysis Probe for its line of expression compact mass spectrometers (CMS). With hundreds of CMS systems utilized in chemistry laboratories around the world, this latest development creates yet another important tool for chemists that need fast, simple, reliable sample analysis of liquids and solids such as reaction mixtures, food samples, natural products and tablets without the need for sample preparation.
Nisin, a common food preservative, may slow or stop squamous cell head and neck cancers, a University of Michigan study found.
Tioga Pharmaceuticals, Inc. announced today that the company has dosed its first subject in a Phase 3 clinical trial to evaluate asimadoline for the treatment of patients with diarrhea-predominant irritable bowel syndrome (DIBS). The trial, referred to as ASMP3001, is the first of two Phase 3 trials being conducted under a Special Protocol Assessment (SPA) agreement with the U.S. Food and Drug Administration (FDA) for U.S. registration. This first trial will be conducted at 120 sites in the U.S.
NeoStem, Inc. an international biopharmaceutical company with product and service revenues, global research and development capabilities and operations in three distinct business units, U.S. adult stem cells, China adult stem cells, and China pharmaceuticals is today providing results of its second quarter 2010.
› Verified 5 days ago
| Entity Name | Beaver Dam Community Hospitals Inc. |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1972188555 PECOS PAC ID: 2567370539 Enrollment ID: O20040210000666 |
News Archive
Advion, Inc., a leading systems and consumables developer for the life sciences industry, announces the release of a Direct Analysis Probe for its line of expression compact mass spectrometers (CMS). With hundreds of CMS systems utilized in chemistry laboratories around the world, this latest development creates yet another important tool for chemists that need fast, simple, reliable sample analysis of liquids and solids such as reaction mixtures, food samples, natural products and tablets without the need for sample preparation.
Nisin, a common food preservative, may slow or stop squamous cell head and neck cancers, a University of Michigan study found.
Tioga Pharmaceuticals, Inc. announced today that the company has dosed its first subject in a Phase 3 clinical trial to evaluate asimadoline for the treatment of patients with diarrhea-predominant irritable bowel syndrome (DIBS). The trial, referred to as ASMP3001, is the first of two Phase 3 trials being conducted under a Special Protocol Assessment (SPA) agreement with the U.S. Food and Drug Administration (FDA) for U.S. registration. This first trial will be conducted at 120 sites in the U.S.
NeoStem, Inc. an international biopharmaceutical company with product and service revenues, global research and development capabilities and operations in three distinct business units, U.S. adult stem cells, China adult stem cells, and China pharmaceuticals is today providing results of its second quarter 2010.
› Verified 5 days ago
| Entity Name | Milwaukee Radiologists Ltd Sc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1568564904 PECOS PAC ID: 7113915810 Enrollment ID: O20040503000756 |
News Archive
Advion, Inc., a leading systems and consumables developer for the life sciences industry, announces the release of a Direct Analysis Probe for its line of expression compact mass spectrometers (CMS). With hundreds of CMS systems utilized in chemistry laboratories around the world, this latest development creates yet another important tool for chemists that need fast, simple, reliable sample analysis of liquids and solids such as reaction mixtures, food samples, natural products and tablets without the need for sample preparation.
Nisin, a common food preservative, may slow or stop squamous cell head and neck cancers, a University of Michigan study found.
Tioga Pharmaceuticals, Inc. announced today that the company has dosed its first subject in a Phase 3 clinical trial to evaluate asimadoline for the treatment of patients with diarrhea-predominant irritable bowel syndrome (DIBS). The trial, referred to as ASMP3001, is the first of two Phase 3 trials being conducted under a Special Protocol Assessment (SPA) agreement with the U.S. Food and Drug Administration (FDA) for U.S. registration. This first trial will be conducted at 120 sites in the U.S.
NeoStem, Inc. an international biopharmaceutical company with product and service revenues, global research and development capabilities and operations in three distinct business units, U.S. adult stem cells, China adult stem cells, and China pharmaceuticals is today providing results of its second quarter 2010.
› Verified 5 days ago
| Entity Name | Memorial Hospital Inc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1346239373 PECOS PAC ID: 2365433224 Enrollment ID: O20040519001426 |
News Archive
Advion, Inc., a leading systems and consumables developer for the life sciences industry, announces the release of a Direct Analysis Probe for its line of expression compact mass spectrometers (CMS). With hundreds of CMS systems utilized in chemistry laboratories around the world, this latest development creates yet another important tool for chemists that need fast, simple, reliable sample analysis of liquids and solids such as reaction mixtures, food samples, natural products and tablets without the need for sample preparation.
Nisin, a common food preservative, may slow or stop squamous cell head and neck cancers, a University of Michigan study found.
Tioga Pharmaceuticals, Inc. announced today that the company has dosed its first subject in a Phase 3 clinical trial to evaluate asimadoline for the treatment of patients with diarrhea-predominant irritable bowel syndrome (DIBS). The trial, referred to as ASMP3001, is the first of two Phase 3 trials being conducted under a Special Protocol Assessment (SPA) agreement with the U.S. Food and Drug Administration (FDA) for U.S. registration. This first trial will be conducted at 120 sites in the U.S.
NeoStem, Inc. an international biopharmaceutical company with product and service revenues, global research and development capabilities and operations in three distinct business units, U.S. adult stem cells, China adult stem cells, and China pharmaceuticals is today providing results of its second quarter 2010.
› Verified 5 days ago
| Entity Name | St Joseph's Health Services Inc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1104031798 PECOS PAC ID: 3971586439 Enrollment ID: O20040615000273 |
News Archive
Advion, Inc., a leading systems and consumables developer for the life sciences industry, announces the release of a Direct Analysis Probe for its line of expression compact mass spectrometers (CMS). With hundreds of CMS systems utilized in chemistry laboratories around the world, this latest development creates yet another important tool for chemists that need fast, simple, reliable sample analysis of liquids and solids such as reaction mixtures, food samples, natural products and tablets without the need for sample preparation.
Nisin, a common food preservative, may slow or stop squamous cell head and neck cancers, a University of Michigan study found.
Tioga Pharmaceuticals, Inc. announced today that the company has dosed its first subject in a Phase 3 clinical trial to evaluate asimadoline for the treatment of patients with diarrhea-predominant irritable bowel syndrome (DIBS). The trial, referred to as ASMP3001, is the first of two Phase 3 trials being conducted under a Special Protocol Assessment (SPA) agreement with the U.S. Food and Drug Administration (FDA) for U.S. registration. This first trial will be conducted at 120 sites in the U.S.
NeoStem, Inc. an international biopharmaceutical company with product and service revenues, global research and development capabilities and operations in three distinct business units, U.S. adult stem cells, China adult stem cells, and China pharmaceuticals is today providing results of its second quarter 2010.
› Verified 5 days ago
| Entity Name | Tri-county Memorial Hospital Inc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1124063573 PECOS PAC ID: 4587642418 Enrollment ID: O20040708000696 |
News Archive
Advion, Inc., a leading systems and consumables developer for the life sciences industry, announces the release of a Direct Analysis Probe for its line of expression compact mass spectrometers (CMS). With hundreds of CMS systems utilized in chemistry laboratories around the world, this latest development creates yet another important tool for chemists that need fast, simple, reliable sample analysis of liquids and solids such as reaction mixtures, food samples, natural products and tablets without the need for sample preparation.
Nisin, a common food preservative, may slow or stop squamous cell head and neck cancers, a University of Michigan study found.
Tioga Pharmaceuticals, Inc. announced today that the company has dosed its first subject in a Phase 3 clinical trial to evaluate asimadoline for the treatment of patients with diarrhea-predominant irritable bowel syndrome (DIBS). The trial, referred to as ASMP3001, is the first of two Phase 3 trials being conducted under a Special Protocol Assessment (SPA) agreement with the U.S. Food and Drug Administration (FDA) for U.S. registration. This first trial will be conducted at 120 sites in the U.S.
NeoStem, Inc. an international biopharmaceutical company with product and service revenues, global research and development capabilities and operations in three distinct business units, U.S. adult stem cells, China adult stem cells, and China pharmaceuticals is today providing results of its second quarter 2010.
› Verified 5 days ago
| Entity Name | Flambeau Hospital, Inc. |
|---|---|
| Entity Type | Part A Provider - Critical Access Hospital |
| Entity Identifiers | NPI Number: 1700963048 PECOS PAC ID: 9032029871 Enrollment ID: O20070828000478 |
News Archive
Advion, Inc., a leading systems and consumables developer for the life sciences industry, announces the release of a Direct Analysis Probe for its line of expression compact mass spectrometers (CMS). With hundreds of CMS systems utilized in chemistry laboratories around the world, this latest development creates yet another important tool for chemists that need fast, simple, reliable sample analysis of liquids and solids such as reaction mixtures, food samples, natural products and tablets without the need for sample preparation.
Nisin, a common food preservative, may slow or stop squamous cell head and neck cancers, a University of Michigan study found.
Tioga Pharmaceuticals, Inc. announced today that the company has dosed its first subject in a Phase 3 clinical trial to evaluate asimadoline for the treatment of patients with diarrhea-predominant irritable bowel syndrome (DIBS). The trial, referred to as ASMP3001, is the first of two Phase 3 trials being conducted under a Special Protocol Assessment (SPA) agreement with the U.S. Food and Drug Administration (FDA) for U.S. registration. This first trial will be conducted at 120 sites in the U.S.
NeoStem, Inc. an international biopharmaceutical company with product and service revenues, global research and development capabilities and operations in three distinct business units, U.S. adult stem cells, China adult stem cells, and China pharmaceuticals is today providing results of its second quarter 2010.
› Verified 5 days ago
| Entity Name | Memorial Hospital Inc |
|---|---|
| Entity Type | Part A Provider - Critical Access Hospital |
| Entity Identifiers | NPI Number: 1346239373 PECOS PAC ID: 2365433224 Enrollment ID: O20110526000807 |
News Archive
Advion, Inc., a leading systems and consumables developer for the life sciences industry, announces the release of a Direct Analysis Probe for its line of expression compact mass spectrometers (CMS). With hundreds of CMS systems utilized in chemistry laboratories around the world, this latest development creates yet another important tool for chemists that need fast, simple, reliable sample analysis of liquids and solids such as reaction mixtures, food samples, natural products and tablets without the need for sample preparation.
Nisin, a common food preservative, may slow or stop squamous cell head and neck cancers, a University of Michigan study found.
Tioga Pharmaceuticals, Inc. announced today that the company has dosed its first subject in a Phase 3 clinical trial to evaluate asimadoline for the treatment of patients with diarrhea-predominant irritable bowel syndrome (DIBS). The trial, referred to as ASMP3001, is the first of two Phase 3 trials being conducted under a Special Protocol Assessment (SPA) agreement with the U.S. Food and Drug Administration (FDA) for U.S. registration. This first trial will be conducted at 120 sites in the U.S.
NeoStem, Inc. an international biopharmaceutical company with product and service revenues, global research and development capabilities and operations in three distinct business units, U.S. adult stem cells, China adult stem cells, and China pharmaceuticals is today providing results of its second quarter 2010.
› Verified 5 days ago
| Entity Name | Gundersen Lutheran Medical Center Inc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1376593442 PECOS PAC ID: 2163331414 Enrollment ID: O20130619000254 |
News Archive
Advion, Inc., a leading systems and consumables developer for the life sciences industry, announces the release of a Direct Analysis Probe for its line of expression compact mass spectrometers (CMS). With hundreds of CMS systems utilized in chemistry laboratories around the world, this latest development creates yet another important tool for chemists that need fast, simple, reliable sample analysis of liquids and solids such as reaction mixtures, food samples, natural products and tablets without the need for sample preparation.
Nisin, a common food preservative, may slow or stop squamous cell head and neck cancers, a University of Michigan study found.
Tioga Pharmaceuticals, Inc. announced today that the company has dosed its first subject in a Phase 3 clinical trial to evaluate asimadoline for the treatment of patients with diarrhea-predominant irritable bowel syndrome (DIBS). The trial, referred to as ASMP3001, is the first of two Phase 3 trials being conducted under a Special Protocol Assessment (SPA) agreement with the U.S. Food and Drug Administration (FDA) for U.S. registration. This first trial will be conducted at 120 sites in the U.S.
NeoStem, Inc. an international biopharmaceutical company with product and service revenues, global research and development capabilities and operations in three distinct business units, U.S. adult stem cells, China adult stem cells, and China pharmaceuticals is today providing results of its second quarter 2010.
› Verified 5 days ago
| Entity Name | Mchs Hospitals Inc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1093221434 PECOS PAC ID: 5698071173 Enrollment ID: O20180208000096 |
News Archive
Advion, Inc., a leading systems and consumables developer for the life sciences industry, announces the release of a Direct Analysis Probe for its line of expression compact mass spectrometers (CMS). With hundreds of CMS systems utilized in chemistry laboratories around the world, this latest development creates yet another important tool for chemists that need fast, simple, reliable sample analysis of liquids and solids such as reaction mixtures, food samples, natural products and tablets without the need for sample preparation.
Nisin, a common food preservative, may slow or stop squamous cell head and neck cancers, a University of Michigan study found.
Tioga Pharmaceuticals, Inc. announced today that the company has dosed its first subject in a Phase 3 clinical trial to evaluate asimadoline for the treatment of patients with diarrhea-predominant irritable bowel syndrome (DIBS). The trial, referred to as ASMP3001, is the first of two Phase 3 trials being conducted under a Special Protocol Assessment (SPA) agreement with the U.S. Food and Drug Administration (FDA) for U.S. registration. This first trial will be conducted at 120 sites in the U.S.
NeoStem, Inc. an international biopharmaceutical company with product and service revenues, global research and development capabilities and operations in three distinct business units, U.S. adult stem cells, China adult stem cells, and China pharmaceuticals is today providing results of its second quarter 2010.
› Verified 5 days ago
| Entity Name | Lakeview Medical Center Inc Of Rice Lake |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1093201832 PECOS PAC ID: 6103737820 Enrollment ID: O20180817001484 |
News Archive
Advion, Inc., a leading systems and consumables developer for the life sciences industry, announces the release of a Direct Analysis Probe for its line of expression compact mass spectrometers (CMS). With hundreds of CMS systems utilized in chemistry laboratories around the world, this latest development creates yet another important tool for chemists that need fast, simple, reliable sample analysis of liquids and solids such as reaction mixtures, food samples, natural products and tablets without the need for sample preparation.
Nisin, a common food preservative, may slow or stop squamous cell head and neck cancers, a University of Michigan study found.
Tioga Pharmaceuticals, Inc. announced today that the company has dosed its first subject in a Phase 3 clinical trial to evaluate asimadoline for the treatment of patients with diarrhea-predominant irritable bowel syndrome (DIBS). The trial, referred to as ASMP3001, is the first of two Phase 3 trials being conducted under a Special Protocol Assessment (SPA) agreement with the U.S. Food and Drug Administration (FDA) for U.S. registration. This first trial will be conducted at 120 sites in the U.S.
NeoStem, Inc. an international biopharmaceutical company with product and service revenues, global research and development capabilities and operations in three distinct business units, U.S. adult stem cells, China adult stem cells, and China pharmaceuticals is today providing results of its second quarter 2010.
› Verified 5 days ago
| Entity Name | Mchs Hospitals Inc |
|---|---|
| Entity Type | Part A Provider - Critical Access Hospital |
| Entity Identifiers | NPI Number: 1952890873 PECOS PAC ID: 5698071173 Enrollment ID: O20180904002962 |
News Archive
Advion, Inc., a leading systems and consumables developer for the life sciences industry, announces the release of a Direct Analysis Probe for its line of expression compact mass spectrometers (CMS). With hundreds of CMS systems utilized in chemistry laboratories around the world, this latest development creates yet another important tool for chemists that need fast, simple, reliable sample analysis of liquids and solids such as reaction mixtures, food samples, natural products and tablets without the need for sample preparation.
Nisin, a common food preservative, may slow or stop squamous cell head and neck cancers, a University of Michigan study found.
Tioga Pharmaceuticals, Inc. announced today that the company has dosed its first subject in a Phase 3 clinical trial to evaluate asimadoline for the treatment of patients with diarrhea-predominant irritable bowel syndrome (DIBS). The trial, referred to as ASMP3001, is the first of two Phase 3 trials being conducted under a Special Protocol Assessment (SPA) agreement with the U.S. Food and Drug Administration (FDA) for U.S. registration. This first trial will be conducted at 120 sites in the U.S.
NeoStem, Inc. an international biopharmaceutical company with product and service revenues, global research and development capabilities and operations in three distinct business units, U.S. adult stem cells, China adult stem cells, and China pharmaceuticals is today providing results of its second quarter 2010.
› Verified 5 days ago
| Entity Name | Flambeau Hospital, Inc. |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1194317966 PECOS PAC ID: 9032029871 Enrollment ID: O20210409000059 |
News Archive
Advion, Inc., a leading systems and consumables developer for the life sciences industry, announces the release of a Direct Analysis Probe for its line of expression compact mass spectrometers (CMS). With hundreds of CMS systems utilized in chemistry laboratories around the world, this latest development creates yet another important tool for chemists that need fast, simple, reliable sample analysis of liquids and solids such as reaction mixtures, food samples, natural products and tablets without the need for sample preparation.
Nisin, a common food preservative, may slow or stop squamous cell head and neck cancers, a University of Michigan study found.
Tioga Pharmaceuticals, Inc. announced today that the company has dosed its first subject in a Phase 3 clinical trial to evaluate asimadoline for the treatment of patients with diarrhea-predominant irritable bowel syndrome (DIBS). The trial, referred to as ASMP3001, is the first of two Phase 3 trials being conducted under a Special Protocol Assessment (SPA) agreement with the U.S. Food and Drug Administration (FDA) for U.S. registration. This first trial will be conducted at 120 sites in the U.S.
NeoStem, Inc. an international biopharmaceutical company with product and service revenues, global research and development capabilities and operations in three distinct business units, U.S. adult stem cells, China adult stem cells, and China pharmaceuticals is today providing results of its second quarter 2010.
› Verified 5 days ago
| Entity Name | Medical Diagnostic Imaging Llc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1427165331 PECOS PAC ID: 0042107641 Enrollment ID: O20220615000858 |
News Archive
Advion, Inc., a leading systems and consumables developer for the life sciences industry, announces the release of a Direct Analysis Probe for its line of expression compact mass spectrometers (CMS). With hundreds of CMS systems utilized in chemistry laboratories around the world, this latest development creates yet another important tool for chemists that need fast, simple, reliable sample analysis of liquids and solids such as reaction mixtures, food samples, natural products and tablets without the need for sample preparation.
Nisin, a common food preservative, may slow or stop squamous cell head and neck cancers, a University of Michigan study found.
Tioga Pharmaceuticals, Inc. announced today that the company has dosed its first subject in a Phase 3 clinical trial to evaluate asimadoline for the treatment of patients with diarrhea-predominant irritable bowel syndrome (DIBS). The trial, referred to as ASMP3001, is the first of two Phase 3 trials being conducted under a Special Protocol Assessment (SPA) agreement with the U.S. Food and Drug Administration (FDA) for U.S. registration. This first trial will be conducted at 120 sites in the U.S.
NeoStem, Inc. an international biopharmaceutical company with product and service revenues, global research and development capabilities and operations in three distinct business units, U.S. adult stem cells, China adult stem cells, and China pharmaceuticals is today providing results of its second quarter 2010.
› Verified 5 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Stephen J Handrich, MD 6150 West Layton Avenue, Greenfield, WI 53220 Ph: (414) 282-4100 | Stephen J Handrich, MD 6150 West Layton Avenue, Greenfield, WI 53220 Ph: (414) 282-4100 |
News Archive
Advion, Inc., a leading systems and consumables developer for the life sciences industry, announces the release of a Direct Analysis Probe for its line of expression compact mass spectrometers (CMS). With hundreds of CMS systems utilized in chemistry laboratories around the world, this latest development creates yet another important tool for chemists that need fast, simple, reliable sample analysis of liquids and solids such as reaction mixtures, food samples, natural products and tablets without the need for sample preparation.
Nisin, a common food preservative, may slow or stop squamous cell head and neck cancers, a University of Michigan study found.
Tioga Pharmaceuticals, Inc. announced today that the company has dosed its first subject in a Phase 3 clinical trial to evaluate asimadoline for the treatment of patients with diarrhea-predominant irritable bowel syndrome (DIBS). The trial, referred to as ASMP3001, is the first of two Phase 3 trials being conducted under a Special Protocol Assessment (SPA) agreement with the U.S. Food and Drug Administration (FDA) for U.S. registration. This first trial will be conducted at 120 sites in the U.S.
NeoStem, Inc. an international biopharmaceutical company with product and service revenues, global research and development capabilities and operations in three distinct business units, U.S. adult stem cells, China adult stem cells, and China pharmaceuticals is today providing results of its second quarter 2010.
› Verified 5 days ago
Robert Breger, MD Radiology Medicare: Accepting Medicare Assignments Practice Location: 6150 West Layton Avenue, Greenfield, WI 53220 Phone: 414-282-4100 Fax: 414-282-4108 | |
Mark S Wenzel, MD Radiology Medicare: Accepting Medicare Assignments Practice Location: 6150 West Layton Avenue, Greenfield, WI 53220 Phone: 414-282-4100 Fax: 414-282-4108 | |
Thomas E Knechtges, MD Radiology Medicare: Not Enrolled in Medicare Practice Location: 6150 West Layton Ave, Greenfield, WI 53220 Phone: 414-282-4100 Fax: 414-282-4108 | |
Anne L Petersen-fisher, MD Radiology Medicare: Not Enrolled in Medicare Practice Location: 6150 West Layton Avenue, Greenfield, WI 53220 Phone: 414-282-4100 Fax: 414-282-4108 | |
Gerald F Splittgerber, MD Radiology Medicare: Medicare Enrolled Practice Location: 6150 West Layton Avenue, Greenfield, WI 53220 Phone: 414-282-4100 Fax: 414-282-4108 | |
Robert Hardie, MD Radiology Medicare: Accepting Medicare Assignments Practice Location: 6150 West Layton Avenue, Greenfield, WI 53220 Phone: 414-282-4100 Fax: 414-282-4108 |